Compugen Ltd (CGEN) 7.03 $CGEN Compugen Discloses

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Compugen Ltd (CGEN) 7.03 $CGEN

Compugen Discloses Development of Enhanced LINKS Platform Utilized for the Discovery of Myeloid Targets for Cancer Immunotherapy
PR Newswire - Tue Aug 30, 6:00AM CDT
Compugen Ltd. (NASDAQ: CGEN), a leading predictive drug discovery company, today disclosed that its LINKS computational platform, initially designed for the characterization and differentiation of existing novel drug target candidates, has been enhanced to include the in silico discovery of new immuno-oncology drug targets, with a specific focus on the discovery of myeloid targets within the tumor microenvironment (TME). LINKS now allows the Company to broaden its existing repertoire of immune checkpoint targets, which already includes a few myeloid targets, predicted by algorithms and methodologies previously developed by the Company. The myeloid targets, now being experimentally validated by the Company, have the potential to transform cancer treatment in patients that are non-responsive to treatments with current checkpoint inhibitors.
CGEN: 7.03 (+0.05)

How Compugen (CGEN) Stock Stands Out in a Strong Industry
Zacks Equity Research - Zacks Investment Research - Thu Aug 18, 7:45AM CDT
Compugen (CGEN) is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective.
CGEN: 7.03 (+0.05)

Compugen Ltd. Reports 2nd Quarter 2016 Financial Results
PR Newswire - Tue Aug 02, 6:01AM CDT
Compugen Ltd. (NASDAQ: CGEN), a leading predictive drug discovery company, today reported financial results for the second quarter ending June 30, 2016.
CGEN: 7.03 (+0.05)

Compugen Discloses Lead Therapeutic Candidate for CGEN-15029 Immuno-Oncology Program
PR Newswire - Wed Jun 22, 6:09AM CDT
Compugen Ltd. (NASDAQ: CGEN), a leading predictive therapeutic discovery company, today disclosed at the JMP Securities Life Science Conference in NY, COM701 as the lead monoclonal antibody therapeutic candidate for the Company's CGEN-15029 target program. This antibody candidate is now undergoing preclinical development activities in preparation for advancement to clinical trials, with an anticipated IND filing next year. CGEN-15029 is one of multiple novel immune checkpoint targets discovered by the Company through the use of its unique in silico predictive discovery infrastructure.
CGEN: 7.03 (+0.05)

Shares of CGEN Up 24.0% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Jun 09, 1:30PM CDT
SmarTrend identified an Uptrend for Compugen (NASDAQ:CGEN) on March 2nd, 2016 at $5.37. In approximately 3 months, Compugen has returned 23.95% as of today's recent price of $6.65.
CGEN: 7.03 (+0.05)

Compugen Has Returned 29.5% Since SmarTrend Recommendation (CGEN)
Comtex SmarTrend(R) - Thu Jun 02, 12:51AM CDT
SmarTrend identified an Uptrend for Compugen (NASDAQ:CGEN) on March 2nd, 2016 at $5.37. In approximately 3 months, Compugen has returned 29.54% as of today's recent price of $6.95.
CGEN: 7.03 (+0.05)

Compugen to Present at the Jefferies Global Healthcare Conference in New York
PR Newswire - Mon May 23, 6:00AM CDT
Compugen Ltd. (NASDAQ: CGEN), a leading predictive drug discovery company, today announced that Ari Krashin, Chief Financial and Operating Officer of Compugen, will present a corporate overview and update at the Jefferies Global Healthcare Conference in New York, NY on Tuesday, June 7, 2016.
CGEN: 7.03 (+0.05)

Compugen Up 26.2% Since SmarTrend Uptrend Call (CGEN)
Comtex SmarTrend(R) - Wed May 18, 12:57AM CDT
SmarTrend identified an Uptrend for Compugen (NASDAQ:CGEN) on March 2nd, 2016 at $5.37. In approximately 3 months, Compugen has returned 26.19% as of today's recent price of $6.77.
CGEN: 7.03 (+0.05)

Compugen to Present at the Oppenheimer Annual Israeli Conference in Tel Aviv
PR Newswire - Mon May 16, 6:00AM CDT
Compugen Ltd. (NASDAQ: CGEN), a leading predictive drug discovery company, today announced that Ari Krashin, Chief Financial and Operating Officer of Compugen, will present a corporate overview and update at the Oppenheimer 17th Annual Israeli Conference in Tel Aviv, Israel on Sunday, May 22, 2016.
CGEN: 7.03 (+0.05)

Compugen Has Returned 31.1% Since SmarTrend Recommendation (CGEN)
Comtex SmarTrend(R) - Tue May 10, 1:34PM CDT
SmarTrend identified an Uptrend for Compugen (NASDAQ:CGEN) on March 2nd, 2016 at $5.37. In approximately 2 months, Compugen has returned 31.13% as of today's recent price of $7.04.
CGEN: 7.03 (+0.05)

Compugen reports 1Q loss
Automated Insights - Tue May 10, 6:14AM CDT
TEL AVIV, Israel (AP) _ Compugen Ltd. (CGEN) on Tuesday reported a loss of $8.6 million in its first quarter.
CGEN: 7.03 (+0.05)

Compugen Ltd. Reports First Quarter 2016 Financial Results
PR Newswire - Tue May 10, 6:01AM CDT
Compugen Ltd. (NASDAQ: CGEN), a leading predictive drug discovery company, today reported financial results for the first quarter ended March 31, 2016.
CGEN: 7.03 (+0.05)

Compugen First Quarter 2016 Conference Call and Webcast Scheduled for Tuesday, May 10, 2016 at 10:00 AM ET
PR Newswire - Wed Apr 27, 6:15AM CDT
Compugen Ltd. (NASDAQ: CGEN), a leading predictive drug discovery company, today announced that the Company will host a conference call at 10:00 AM ET on Tuesday, May 10, 2016, to review the first quarter 2016 results. The quarterly results will be released on the Company's website (www.cgen.com) prior to the conference call.
CGEN: 7.03 (+0.05)

31.0% Return Seen to Date on SmarTrend Compugen Call (CGEN)
Comtex SmarTrend(R) - Fri Apr 22, 12:44AM CDT
SmarTrend identified an Uptrend for Compugen (NASDAQ:CGEN) on March 2nd, 2016 at $5.37. In approximately 2 months, Compugen has returned 31.03% as of today's recent price of $7.03.
CGEN: 7.03 (+0.05)

Compugen Achieves Preclinical Milestone in Cancer Immunotherapy Collaboration With Bayer
PR Newswire - Mon Apr 18, 6:14AM CDT
Compugen Ltd. (NASDAQ: CGEN ), a leading predictive drug discovery company, announced today that it has achieved a first preclinical milestone for CGEN-15022 pursuant to its cancer immunotherapy collaboration with Bayer. The collaboration provides for the research, development, and commercialization of antibody-based cancer therapeutics against two novel Compugen-discovered immune checkpoint regulators, CGEN-15001T and CGEN-15022.
CGEN: 7.03 (+0.05)

Dr. Elliott Sigal Joins Compugen Ltd. as Strategic Advisor and Prof. Drew Pardoll Appointed Director at Compugen USA, Inc.
PR Newswire - Wed Apr 06, 6:00AM CDT
Compugen Ltd. (NASDAQ: CGEN), a leading predictive drug discovery company, announced today that Elliott Sigal, M.D., Ph.D., former Executive Vice President and Director of Bristol-Myers Squibb, has joined Compugen Ltd. as a strategic advisor. The Company also announced that Drew Pardoll, M.D., Ph.D., Abeloff Professor of Oncology, Medicine, Pathology, and Molecular Biology and Genetics and Director of the Bloomberg~Kimmel Institute for Cancer Immunotherapy at the Sidney Kimmel Cancer Center at Johns Hopkins University of Medicine, and Chairman of Compugen's Scientific Advisory Board, has in addition joined the Board of Directors of Compugen USA, Inc., Compugen Ltd.'s wholly-owned antibody discovery and development subsidiary.
CGEN: 7.03 (+0.05), BMY: 57.39 (+0.15)

Compugen to Present at the Jefferies Immuno-Oncology Summit in Boston
PR Newswire - Mon Mar 28, 6:00AM CDT
Compugen Ltd. (NASDAQ: CGEN), a leading predictive drug discovery company, today announced that Anat Cohen-Dayag, Ph.D., President and Chief Executive Officer of Compugen, will present an overview of the Company's immuno-oncology programs and underlying predictive discovery capabilities at the Jefferies 2016 Immuno-Oncology Summit in Boston, on Thursday, April 7, 2016.
CGEN: 7.03 (+0.05)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Halfday Iced Tea Shakes Up U.S. Retail Scene

Updated Category News Views 108

Halfday's Meteoric Rise in the U.S. Market Sometimes, you pick up a can of iced tea, and it just changes the game. That’s exactly what Halfday is doing, stepping on the accelerator and leaving traditional iced tea brands in the dust. With their latest announcement, they've snagged the title of the fastest-growing modern tea brand in U.S. multi-outlet retail. It's the...

Continue Reading
Graphic Packaging Shakes Up Leadership and Supply Chain

Updated Category News Views 7

New Leadership Takes the Helm at Graphic Packaging What do you do when you want to streamline an operation that spans continents? Well, if you're Graphic Packaging Holding Company (NYSE: GPK), you bring in fresh leadership to serenade the chaos into a well-oiled machine. Starting December 1, 2026, D. Keith Hamilton will be sinking his teeth into North America Mills &...

Continue Reading
Cargo Drones to Skyrocket with $9.14B Value by 2031

Updated Category News Views 87

Riding the Drone Wave I tell you what, folks, the whole business of cargo drones is getting frickin' interesting. These flying gizmos, once dismissed as science fiction, are now barging their way into logistics discussions like an uninvited guest who's too worthwhile to ignore. MarketsandMarkets™ reckons this market's about to smash through the $9 billion ceiling by...

Continue Reading
IP Lawyer Chris Henry Returns to Latham: A Game Changer

Updated Category News Views 22

Welcome Home, Chris Henry! Folks, here's a headline that's making waves in the IP litigation water: Chris Henry has returned to Latham & Watkins, taking his place as a heavyweight partner in their Boston office. Now, if you're not deeply entangled in the world of high-stakes intellectual property (IP) disputes, you might shrug. But for tech companies embroiled in patent...

Continue Reading
NCPDP Elevates J.W. Hill to President & COO Role

Updated Category News Views 9

Plotting the Course for NCPDP's Future Today's shakeup at the NCPDP has got the sector's ears perked. For those who don't speak in acronym soup all day—NCPDP stands for National Council for Prescription Drug Programs. They're the brains behind many crucial healthcare standards, improving information flow around meds, supplies, and services. Now, they're taking bold...

Continue Reading
Cinmoore's Smart Camera: A Game Changer for Car Security

Updated Category News Views 43

Pioneering Car Security with Cinmoore's Smart Camera Ever left your car in the parking lot, heart pounding, wondering if it's safe while you run errands? Well, Cinmoore might just quell that parking paranoia with their new gizmo, the Smart Parking Camera DC1U. This device isn't just some fancily-packaged disappointment—it promises some serious peace of mind for those...

Continue Reading
HKEX Unveils New Offshore RMB Bond Index

Updated Category News Views 211

Here's the scoop: Hong Kong Exchanges and Clearing Limited (HKEX) just rolled out something worth eyeing—the HKEX Offshore RMB Bond Index. It's the first of its kind from HKEX, catered to those Dim Sum bonds floating around in the city. With Bloomberg lending a hand on the index smarts, this step is poised to give Hong Kong a leg up in the global financial marathon....

Continue Reading
Inventor Launches Handy Solution for Kids' Car Sickness

Updated Category News Views 0

A Fresh Take on an Age-Old Problem Just when you thought the universe had thrown all it could at beleaguered parents, here comes a nifty little accessory tackling those dreaded uphill battles with kids and car rides. Some bright spark from Middleburgh, New York, sick of scrubbing car seats and clothing every other road trip, came up with a clever little invention named...

Continue Reading
KuCoin Unveils $1.1M USDT Black Friday Bonanza

Updated Category News Views 110

KuCoin's Festive Fireworks: Black Friday Bonanza Sometimes the crypto world feels like a carnival, and KuCoin's latest act is the $1.1 million USDT prize pool, rolling out as part of its 'Tis The Season holiday campaign. A move that matches the glitz of Tomorrowland Winter experiences, adding more sparkle to the crypto stage. Behind the Scenes of the KuCoin-Tomorrowland...

Continue Reading
Alley Cat Allies Pushes for Humane Cat Conservation Bill

Updated Category News Views 22

Time to Rethink Conservation: Save the Cats If you’re tuned into the chatter buzzing around the Cayman Islands, you know the clocks are ticking for a decision that could change the approach to handling community cats. Alley Cat Allies is waving the flag, urging the Cayman Islands Parliament to pass a bill that abandons the archaic practice of culling cats by shooting...

Continue Reading

Top 5 Most Recently Viewed Articles

Warren Buffett's Wisdom: Rethinking Your Stock Strategy

Updated Category News Views 155

Billionaire investor Warren Buffett became a titan in finance through his distinctive approach to stock investing, one that flips conventional wisdom on its head. While most folks lose their heads when prices drop, Buffett sees opportunity. When stocks go down, he doesn’t cry; he gets excited. "I love it when the things we buy go down," he said in a reflective moment...

Continue Reading
Kenneth L Calloway's $452K Share Sale: What It Means for CENX

Updated Category News Views 220

Understanding the Recent Insider Trade in Century Aluminum In a notable move that has caught the attention of investors, Kenneth L Calloway, the Senior Vice President at Century Aluminum, recently sold a significant amount of stocks. The transaction, which took place recently and is detailed in an SEC filing, involved the sale of 16,450 shares valued at approximately...

Continue Reading
Jura Energy Corporation Releases Key Financial Information

Updated Category News Views 213

Jura Energy Corporation Financial Filings Overview Jura Energy Corporation has recently announced an important update regarding its financial performance. The company has filed its condensed consolidated interim financial statements for the periods ending June 30 for both 2025 and 2024 on SEDAR. Alongside these financial statements, Jura has also released its...

Continue Reading
Exploring the Surge in Edge Computing Growth and Its Impact

Updated Category News Views 207

Understanding Edge Computing Growth Dynamics The edge computing market is poised for significant growth, projected to increase by USD 19.6 billion during the period between 2024 and 2028. This advancement is primarily fueled by the rising demand for decentralized computing, aimed at minimizing latency in decision-making processes. Technological advancements heralding...

Continue Reading
Hiab's Q3 Report 2025: Navigating Challenges with Resilience

Updated Category News Views 239

Hiab's Financial Journey in Q3 2025: An Overview Hiab's latest quarterly report sheds light on the company's performance amidst swirling market uncertainties. The recent challenges stemmed primarily from lower sales figures in parts of their market, particularly in the United States, affecting profitability. Key Highlights of the Quarterly Performance The first major...

Continue Reading